2012•Вопросы современной педиатрииOpen access

EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS

L. A. Galstyan, Е С Жолобова, O. S. Razvadovskaya, A. V. Bunin, A. V. Starikova

Abstract

A history case of a female patient with juvenile idiopathic arthritis, resistant to steroids and methotrexate and secondary resistance to infliximab, is represented in this article. Switching to another tumor necrosis factor-alpha inhibitor — adalimumab — led to induction of steady remission of joint syndrome and uveitis, steroids, methotrexate and non-steroidal anti-inflammatory drugs withdrawal.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Adalimumab, Methotrexate, Uveitis, Medicine, Infliximab, Arthritis, Juvenile, Tumor necrosis factor alpha